Cantore, Maurizio <br/><br/>
Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.  [electronic resource] 

 -  Cancer  Apr 2005 
 - 1402-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.20964  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Biliary Tract Neoplasms--drug therapy<br/>Cholangiocarcinoma--drug therapy<br/>Cisplatin--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Hepatic Artery<br/>Humans<br/>Infusions, Intra-Arterial<br/>Male<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Survival Rate<br/>Venous Thrombosis--etiology